Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 8, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	503,792	487,808	623,943	306,419	188,183	222,339	Upgrade
Market Cap Growth	-1.62%	-21.82%	103.62%	62.83%	-15.36%	110.39%	Upgrade
Last Close Price	110.63	103.37	129.31	68.56	40.30	59.64	Upgrade
PE Ratio	5.31	5.11	9.51	7.98	5.39	10.68	Upgrade
PS Ratio	1.64	1.64	2.45	1.50	1.06	1.56	Upgrade
PB Ratio	0.62	0.60	0.88	0.51	0.33	0.44	Upgrade
Debt / Equity Ratio	1.53	1.53	1.14	1.07	0.47	0.65	Upgrade
Return on Equity (ROE)	-	12.60%	10.00%	6.55%	6.53%	4.36%	Upgrade
Return on Assets (ROA)	-	0.97%	0.75%	0.49%	0.47%	0.30%	Upgrade
Earnings Yield	18.84%	19.57%	10.52%	12.53%	18.56%	9.37%	Upgrade
FCF Yield	-	-125.84%	-118.13%	-162.79%	-196.31%	-153.79%	Upgrade
Dividend Yield	3.62%	3.92%	2.17%	2.92%	4.96%	-	Upgrade
Payout Ratio	19.43%	13.35%	12.50%	21.38%	-	-	Upgrade
Buyback Yield / Dilution	-4.57%	-7.35%	-3.35%	-6.51%	-17.53%	-0.86%	Upgrade
Total Shareholder Return	-0.95%	-3.43%	-1.18%	-3.59%	-12.57%	-0.86%	Upgrade

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.